Prolactin up-regulates cathepsin B and D expression in minor salivary glands of patients with Sjogren's syndrome

Laboratory Investigation

Volumn 80, Issue 11, 2000, Pages 1711-1720

  Steinfeld, Serge ^a   Maho, Arielle ^b   Chaboteaux, Carole ^b   Daelemans, Philippe ^a   Pochet, Roland ^b   Appelboom, Thierry ^a   Kiss, Robert ^b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN D; PROLACTIN; PROTEINASE;

ACINAR CELL; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MICROSCOPY; MINOR SALIVA GLAND; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SJOEGREN SYNDROME;

EID: 0033746322     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780181     Document Type: Article

References (49)

1. Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies
2. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease
3. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
4. Role of cytokines in the destruction of acinar structure in Sjogren's syndrome salivary glands
5. Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice
6. Influence of gastrin on human astrocytic tumor cell proliferation
7. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells
8. Emerging roles for cysteine proteases in human biology
9. A model to study viral and cytokine involvement in Sjogren's syndrome
10. Epitope-directed processing of specific antigen by B lymphocytes
11. Cathepsin D protease mediates programmed cell death induced by interferon-γ, Fas/APO-1 and TNF-α
12. Linkage studies of HLA and primary Sjogren's syndrome in multicase families
13. Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjogren's syndrome
14. Sjogren's syndrome: Proposed criteria for classification
15. Pathogenesis of Sjogren's syndrome
16. Molecular regulation, membrane association and secretion of tumor cathepsin B
17. Cellular distribution of prolactin receptors in human digestive tissues
18. Gonadotrophin-releasing hormone agonist has the ability to induce increased matrix metalloproteinase (MMP)-2 and membrane type 1-MMP expression in corpora lutea, and structural luteolysis in rats
19. Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals
20. Salivary and serum interleukin 6 in primary Sjogren' syndrome
21. A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: Saliva from patients with Sjogren's syndrome contains increased latent and active gelatinase-B levels
22. Stimulation of matrix-metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expression in rats by the preovulatory prolactin peak
23. Hypofunction of the stress axis in Sjogren's syndrome
24. A method to study induction of autoimmunity in vitro: Co-culture of lacrimal cells and autologous immune system cells
25. Distinct immunologic features of Finnish Sjogren's syndrome patients with HLA alleles DRB1*0301, DQA1*0501 and DQB1*0201
26. Molecular regulation of B lymphocyte response
27. Collagenase in Sjogren's syndrome
28. Structure and transcriptional regulation of the ovine placental lactogen gene
29. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain
30. Cathepsin B
31. Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis
32. Identification of latent procathepsins B and L in microsomal lumen: Characterization of enzymatic activation and proteolytic processing in vitro
33. Prolactin in autoimmune diseases
34. Subcellular distribution of Ro ribonucleoprotein complexes and their constituents
35. Homocamptothecin, an E-ring modified camptothecin, exerts more potent antiproliferative activity than other topoisomerase I inhibitors in human colon cancers obtained from surgery and maintained in vitro under histotypical culture conditions
36. The immunogenetics of Sjogren's syndrome
37. HLA class II phenotype controls diversification of the autoantibody response in primary Sjogren's syndrome
38. Cathepsins as effector proteases in hepatocyte apoptosis
39. Elevated levels of cysteine protease activity in the saliva and salivary glands of non-obese diabetic (NOD) mouse model for Sjogren's syndrome
40. Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: A potential trigger for sialoadenitis in NOD mice
41. The submandibular gland: A key organ in the neuroimmunoregulatory network?
42. Lectin histochemistry, ploidy level and proliferation indices in meningioma subtypes
43. The aspartic proteases
44. D-Mannose and N-acetylglucosamine moieties and their respective binding sites in salivary glands of Sjogren's syndrome
45. Big prolactin 60kDa is overexpressed in salivary glandular epithelial cells from patients with Sjogren's syndrome
46. Activities of cathepsin D in rat prostate during castration-induced involution
47. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community
48. Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-γ in a human salivary gland cell line
49. MHC class II molecules, cathepsins, and La/SSB proteins in lacrimal acinar cell endomembranes